Virginia Retirement Systems’s Revance Therapeutics, Inc. RVNC Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-13,700	Closed	-$347K	–	1053
2023 Q2	$347K	Sell	13,700 -300	-2%	-$7.59K	﹤0.01%	809
2023 Q1	$451K	Buy	14,000 +900	+7%	+$29K	﹤0.01%	770
2022 Q4	$242K	Buy	+13,100	New	+$242K	﹤0.01%	1015
2022 Q1	$433K	Buy	+22,200	New	+$433K	﹤0.01%	887